Pharmafile Logo
Pharmafocus logo
Advanced Search
michael_cohen

Novartis caught in the Stormy Daniels affair, after huge payment to Trump’s lawyer

May 9, 2018
Medical Communications, Research and Development Cohen, Novartis, President trump, Trump, biotech, drugs, pharma, pharmaceutical

Novartis has suddenly found itself embroiled in the Stormy Daniels affair, after the lawyer representing her, Michael Avenatti, included the …

News
credit_-_daniel_leal-olivas-afp

European approval for tablet formulation of Lynparza in ovarian cancer

May 8, 2018
Research and Development, Sales and Marketing AstraZeneca, Cancer, EMA, Europe, MSD, lynparza, ovarian cancer, pharma

AstraZeneca and MSD’s poly ADP-ribose polymerase (PARP) inhibitor Lynparza (olaparib) has been approved for use in Europe, it has emerged, …

News
eye

All eyes on dry eye disease

May 8, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing TopiVert, dry eye disease, eye, pharma

Dr Matthew Fyfe, Head of Chemistry and Intellectual Property at TopiVert, gives an illuminating look into the latest developments in …

Feature
novartis_side_building

FDA approves Novartis combo in rare thyroid cancer subtype

May 8, 2018
Manufacturing and Production, Sales and Marketing Cancer, FDA, Tafinlar, mekinist, thyroid cancer

The FDA has announced its decision to approve the use of Novartis’ combination of Tafinlar (dabrafenib) and Mekinist (trametinib) in …

News
jj

J&J’s ketamine-based antidepressant showed mixed success at Phase 3

May 8, 2018
Manufacturing and Production, Research and Development, Sales and Marketing J&J, JJ, Johnson & Johnson, Ketamine, antidepressant, depression, esketamine, pharma

Johnson & Johnson has revealed new data on its new depression drug esketamine, its chemically ‘left-handed’ version of the controlled …

News

Genmab and Janssen’s Darzalex combo scores FDA approval in multiple myeloma

May 8, 2018
Manufacturing and Production, Sales and Marketing FDA, Genmab, Janssen, US, darzalex, multiple myeloma, pharma

Genmab and Janssen have revealed that their combination of Darzalex (daratumumab) with bortezomib (Velcade), melphalan, and prednisone (VMP) has received …

News
astrazeneca_sign_sky

AstraZeneca jettisons schizophrenia drug for $538 million

May 8, 2018
Manufacturing and Production, Sales and Marketing AstraZeneca, Luye Pharma, Seroquel, pharma, schizophrenia

AstraZeneca has confirmed it has signed a deal to jettison its schizophrenia drug Seroquel and its extended release version Seroquel …

News
takeda_global_hq

It’s official: Takeda to buy Shire for £46 billion

May 8, 2018
Manufacturing and Production, Sales and Marketing Shire, Takeda, acquisition, pharma

After more than a month of uncertainty, Takeda has finally confirmed it has managed to successfully acquire Shire, agreeing on …

News
top_ten

Top Ten most popular articles on Pharmafile.com this week

May 4, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, EMA, Kymriah, Novartis, Porton Biopharma, Regeneron, Roche, Sandoz, Sanofi, Shire, Takeda, biosimilars, dementia

It’s Friday again and it’s been a week busy with companies’ financials. One company’s in particular were of note due …

News
opioid_therapy_credit_-_us_air_force_valerie_monroy

Los Angeles becomes latest US city to sue pharma over opioid crisis

May 4, 2018
Medical Communications, Sales and Marketing Los Angeles, opioid crisis, pharma

The city of Los Angeles has levied legal action against a number of pharmaceutical firms for their role in advancing …

News
baby-784607_960_720

Mallinckrodt gets two thumbs down from FDA for jaundice drug

May 4, 2018
Medical Communications, Sales and Marketing InfaCare, Mallinckrodt, biotech, drugs, pharma, pharmaceutical

Mallinckrodt paid $80 million, with a further $345 million dependent on milestones, to acquire InfaCare in the hope that the …

News
webinar

Free webinar – Rational EU risk management for oncology medicines

May 4, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA Group, biotech, drugs, pharma, pharmaceutical

It is timely to reflect on how we can best implement the revised GVP module (V) concerning risk management in …

News
bms

BMS looks to leverage real-world data, with Flatiron collab

May 3, 2018
Medical Communications, Sales and Marketing Bristol-Myers Squibb, Flatiron health, biotech, drugs, pharma, pharmaceutical

Bristol-Myers Squibb has extended its existing collaboration with Flatiron Health by three years and expanded the efforts both will be …

News
sugar_tax

The UK sugar tax: A sweet or sour move?

May 3, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UK, obesity, pharma, sugar tax

Dr Daniel Bailey, Senior Lecturer in Health, Nutrition and Exercise at the University of Bedfordshire, discusses the benefits of the …

Feature
nerves

New study argues the importance of existing anti-inflammatory drugs in fighting dementia

May 3, 2018
Research and Development Alzheimer's, dementia, pharma

Research into dementia has waned in recent times as researchers struggle to pin down concrete advancements, leading to the withdrawal …

News
ecstasy_monogram

Recreational drug MDMA proves efficacy in reducing PTSD symptoms, new study finds

May 3, 2018
Research and Development MDMA, PTSD, pharma

Promising new findings have been revealed in the efficacy of MDMA in treating post-traumatic stress disorder (PTSD).

News
veeva_event

Speakers Announced for Veeva R&D Summit, Europe

May 3, 2018
Medical Communications biotech, drugs, pharma, pharmaceutical, veeva

In the pharma industry, we tend to use a lot of acronyms. Even in every day life, we are shortening …

News

Sandoz US woes continue with biosimilar rejection

May 3, 2018
Sales and Marketing Novartis, Sandoz, biosimilars, biotech, drugs, pharma, pharmaceutical

In Novartis’ recently released Q1 results, which largely beat analysts’ estimates, Sandoz was a black spot on its record – …

News
jeremy_hunt

450,000 missed breast cancer screenings, 270 lives potentially shortened

May 2, 2018
Medical Communications Jeremy Hunt, NHS, UK, biotech, drugs, pharma, pharmaceutical

An error in the automated system left 450,000 women without an invite for breast screening and Jeremy Hunt, the UK’s …

News

BMS pulls the plug on Phase 3 trials of IDO1 inhibitor

May 2, 2018
Research and Development BMS, Bristol-Myers Squibb, IDO1, opdivo, pharma, phase 3

Bristol-Myers Squibb has terminated two pivotal Phase 3 trials of BMS-986205, an IDO1 inhibitor acquired through its $800 million acquisition …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026